$19.09
-0.10%FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Chairman, President, Chief Executive Officer & Treasurer
Compensation
$372,885
Chief Operating Officer, Executive Vice President & Acting Principal Financial Officer
Compensation
$498,241
Director of Communications
Secretary & Director
Compensation
$58,880
During the last 12 months, insiders have purchased $5.65M worth of FONR shares, with no selling activity reported.
297.0K
5.65M
0
0.00
+5.7M
+$5.65M
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
Shane Hilary
10 Percent Owner
$5.65M
No selling activity
Strong bullish signal with $5.65M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.
FONR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 07, 2025 | May 19, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 08, 2024 | May 20, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 06, 2023 | May 22, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 08, 2022 | May 23, 2022 | 2022 | |
DEF 14A DEF 14A 2020 N/A | April 07, 2021 | June 30, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 29, 2020 | June 30, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 05, 2019 | June 30, 2018 | 2018 | |
DEF 14A DEF 14A 2018 N/A | May 02, 2018 | June 30, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | April 26, 2017 | June 30, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.